Phase I/II Adaptive Dose-Finding Design for MTA
Description
Phase I/II adaptive dose-finding design for single-agent
Molecularly Targeted Agent (MTA), according to the paper "Phase
I/II Dose-Finding Design for Molecularly Targeted Agent: Plateau
Determination using Adaptive Randomization", Riviere Marie-Karelle et
al. (2016) .